Literature DB >> 33627720

Machine learning approaches for the prediction of bone mineral density by using genomic and phenotypic data of 5130 older men.

Qing Wu1,2, Fatma Nasoz3,4, Jongyun Jung5,6, Bibek Bhattarai3, Mira V Han5,7, Robert A Greenes8,9, Kenneth G Saag10.   

Abstract

The study aimed to utilize machine learning (ML) approaches and genomic data to develop a prediction model for bone mineral density (BMD) and identify the best modeling approach for BMD prediction. The genomic and phenotypic data of Osteoporotic Fractures in Men Study (n = 5130) was analyzed. Genetic risk score (GRS) was calculated from 1103 associated SNPs for each participant after a comprehensive genotype imputation. Data were normalized and divided into a training set (80%) and a validation set (20%) for analysis. Random forest, gradient boosting, neural network, and linear regression were used to develop BMD prediction models separately. Ten-fold cross-validation was used for hyper-parameters optimization. Mean square error and mean absolute error were used to assess model performance. When using GRS and phenotypic covariates as the predictors, all ML models' performance and linear regression in BMD prediction were similar. However, when replacing GRS with the 1103 individual SNPs in the model, ML models performed significantly better than linear regression (with lasso regularization), and the gradient boosting model performed the best. Our study suggested that ML models, especially gradient boosting, can improve BMD prediction in genomic data.

Entities:  

Mesh:

Year:  2021        PMID: 33627720      PMCID: PMC7904941          DOI: 10.1038/s41598-021-83828-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  32 in total

Review 1.  Genetics of osteoporosis.

Authors:  J A Eisman
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

2.  A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation.

Authors:  M R Nelson; S L Kardia; R E Ferrell; C F Sing
Journal:  Genome Res       Date:  2001-03       Impact factor: 9.043

3.  Use of classification trees for association studies.

Authors:  H Zhang; G Bonney
Journal:  Genet Epidemiol       Date:  2000-12       Impact factor: 2.135

Review 4.  Epidemiology and outcomes of osteoporotic fractures.

Authors:  Steven R Cummings; L Joseph Melton
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

5.  World-wide projections for hip fracture.

Authors:  B Gullberg; O Johnell; J A Kanis
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 6.  Detecting gene-gene interactions that underlie human diseases.

Authors:  Heather J Cordell
Journal:  Nat Rev Genet       Date:  2009-06       Impact factor: 53.242

7.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

Authors:  D Marshall; O Johnell; H Wedel
Journal:  BMJ       Date:  1996-05-18

8.  Efficient haplotype matching and storage using the positional Burrows-Wheeler transform (PBWT).

Authors:  Richard Durbin
Journal:  Bioinformatics       Date:  2014-01-09       Impact factor: 6.937

9.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

10.  Predicting urinary tract infections in the emergency department with machine learning.

Authors:  R Andrew Taylor; Christopher L Moore; Kei-Hoi Cheung; Cynthia Brandt
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

View more
  1 in total

1.  Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach.

Authors:  Dionna Jacobson; Benoit Cadieux; Celestia S Higano; David H Henry; Basia A Bachmann; Marko Rehn; Alison T Stopeck; Hossam Saad
Journal:  J Bone Oncol       Date:  2022-03-17       Impact factor: 4.072

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.